Sarini J - Search Results

1

Risk factors for wound infection in head and neck cancer surgery: a prospective study.

Penel N, Lefebvre D, Fournier C, Sarini J, Kara A, Lefebvre JL. Penel N, et al. Among authors: sarini j. Head Neck. 2001 Jun;23(6):447-55. doi: 10.1002/hed.1058. Head Neck. 2001. PMID: 11360305

2

[Current knowledge on the action of retinoids in carcinoma of the head and neck].

Dolivet G, Ton Van J, Sarini J, Wattel E, Lagarde P, Chomy F, Lefebvre JL. Dolivet G, et al. Among authors: sarini j. Rev Laryngol Otol Rhinol (Bord). 1996;117(1):19-26. Rev Laryngol Otol Rhinol (Bord). 1996. PMID: 8734261 Review. French.

3

[Anticancer chemotherapy, risk factor for infection at the operated site in cervicofacial surgery].

Penel N, Fournier C, Kara A, Sarini J, Lefebvre D. Penel N, et al. Among authors: sarini j. Presse Med. 2001 May 19;30(18):892-5. Presse Med. 2001. PMID: 11413843 French.

4

Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases.

Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequéant B. Sarini J, et al. Arch Otolaryngol Head Neck Surg. 2001 Sep;127(9):1089-92. doi: 10.1001/archotol.127.9.1089. Arch Otolaryngol Head Neck Surg. 2001. PMID: 11556858

5

[Induction chemotherapy and larynx preservation: is such practice useful?].

Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL. Sarini J, et al. Bull Cancer. 2002 Apr;89(4):411-7. Bull Cancer. 2002. PMID: 12016041 Free article. French.

6

Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study.

Penel N, Fournier C, Lefebvre D, Roussel-Delvallez M, Sarini J, Kara A, Mallet Y, Lefebvre JL. Penel N, et al. Among authors: sarini j. Head Neck. 2004 Jun;26(6):513-7. doi: 10.1002/hed.20002. Head Neck. 2004. PMID: 15162352

7

Modification of the infra hyoid musculo-cutaneous flap.

Dolivet G, Gangloff P, Sarini J, Ton Van J, Garron X, Guillemin F, Lefebvre JL. Dolivet G, et al. Among authors: sarini j. Eur J Surg Oncol. 2005 Apr;31(3):294-8. doi: 10.1016/j.ejso.2004.10.006. Eur J Surg Oncol. 2005. PMID: 15780566

8

Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma.

Thomas F, Rochaix P, Benlyazid A, Sarini J, Rives M, Lefebvre JL, Allal BC, Courbon F, Chatelut E, Delord JP. Thomas F, et al. Among authors: sarini j. Clin Cancer Res. 2007 Dec 1;13(23):7086-92. doi: 10.1158/1078-0432.CCR-07-1370. Clin Cancer Res. 2007. PMID: 18056187 Clinical Trial.

9

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma.

Thomas F, Rochaix P, White-Koning M, Hennebelle I, Sarini J, Benlyazid A, Malard L, Lefebvre JL, Chatelut E, Delord JP. Thomas F, et al. Among authors: sarini j. Eur J Cancer. 2009 Sep;45(13):2316-23. doi: 10.1016/j.ejca.2009.05.007. Epub 2009 Jun 10. Eur J Cancer. 2009. PMID: 19523815

10

Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinoma.

Thomas F, Delmar P, Vergez S, Rochaix P, Hennebelle I, McLoughlin P, Benlyazid A, Sarini J, Delord JP. Thomas F, et al. Among authors: sarini j. Head Neck. 2013 Jun;35(6):809-18. doi: 10.1002/hed.23036. Epub 2012 Jul 13. Head Neck. 2013. PMID: 22791662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters